MIRD-226 is a beta-emitting radioisotope, which means it releases beta particles (electrons) during its decay process. This property makes it suitable for various medical applications, including cancer treatment, imaging, and research. The energy spectrum of MIRD-226 beta particles ranges from 0.3 to 1.5 MeV, which is relatively low compared to other radioisotopes.
MIRD-226! That's a fascinating topic. MIRD-226, also known as "MIRD Schema," is a standardized method for describing and reporting the absorbed dose of radiation in nuclear medicine and radiation therapy. MIRD-226
The reports and guidelines issued by MIRD are highly valued for several reasons: MIRD-226 is a beta-emitting radioisotope, which means it